The Patient-Centric Approach in Health Economics

By Staff Writer

January 24, 2024

A Paradigm Shift in Health Economics and Outcomes Research

HEOR, which refers to health economics and outcomes research, is a realm that is difficult to navigate due to its complexity, diverse nature, and numerous facets. Nevertheless, there is one key element that stands out: the patient is the most important element. With the purpose of shedding light on the influence that this trend has on healthcare systems around the world, this article investigates the increased emphasis on a patient-centric approach in HEOR.

The Core of Health and Education

At its core, HEOR is a multidisciplinary field that aims to enhance the accessibility, fairness, and efficiency of healthcare systems for patients. It requires an understanding and appreciation of factors that significantly affect patients’ health and their experiences. This field prioritises what truly matters to patients.

The Importance of ISPOR in the Support of Patient-Centred Patient Care

Rob Abbott, as the CEO and Executive Director of The International Society for Pharmacoeconomics and Outcomes Research (ISPOR), emphasised the importance of encouraging patient-focused work. He defined this as a collaborative and meaningful interaction between patients and researchers, occurring throughout the entire research process. During the decision-making process, patient experiences, values, and expertise serve as guiding principles. This helps to ensure that the data collected ultimately contributes to the improvement of patient outcomes.

Progress and Obstacles

Significant progress has been made in centering patients in HEOR, but much work remains. We need to boost the patient’s voice and create a more patient-focused decision-making process. However, integrating the patient throughout the entire healthcare journey presents significant challenges. 

Regarding the Future Strategy of ISPOR and the Function of HEOR

As ISPOR moves on with a new plan for the year 2024, it is making concerted efforts to establish HEOR as a crucial instrument for addressing the most significant challenges in the field of global healthcare. Affordability, the impact of the rapid digitalisation of health care, and the increased desire in providing comprehensive health care are some of these factors. The patient, on the other hand, is the focal point of each and every one of these issues.

Concluding remarks

When it comes to HEOR, the patient-centric approach focuses not only on improving people’s health but also on improving the patient experience in situations where their health has been compromised. In this context, it refers to making sure that the patients’ voices are heard and that their requirements are addressed.

Reference url

Recent Posts

CAB–LA cost-effectiveness
    

Cost-Effective HIV PrEP: CAB-LA Transforms Prevention

💡 Can CAB-LA revolutionize HIV prevention for underserved communities?

A new study confirms CAB-LA’s cost-effectiveness as HIV PrEP, preventing 4.5 more infections per 100 users than oral PrEP and saving $42,517 in healthcare costs. It significantly benefits African American/Black MSM and cisgender women, aligning with EHE goals.

Explore how CAB-LA reshapes HIV prevention! Read the full article.

#SyenzaNews #HealthEconomics #HealthcareInnovation #CostEffectiveness

global health limitations
    

Global Health Limitations: A Critical Assessment of Structural Constraints and Opportunities

🌍 Are we truly addressing the roots of global health inequities, or are we just treating the symptoms?

In his compelling article, Jesse B. Bump dives into the historical forces shaping global health, revealing how colonial legacies and macroeconomic constraints limit our ability to achieve health equity. He challenges the status quo by urging a deeper engagement with the structures that govern resource distribution and health outcomes.

Curious to learn more about the intricate dynamics at play in global health and how they affect our collective progress?

#SyenzaNews #globalhealth #HealthEconomics #healthcarepolicy

neoadjuvant immunotherapy efficacy
           

Neoadjuvant Immunotherapy Efficacy: Enhancing Treatment Strategies for Head and Neck Cancer

🚀 Are you ready to explore a potential breakthrough in cancer treatment?

Recent research on neoadjuvant immunotherapy for head and neck squamous cell carcinoma unveils the promise of combination therapies, showcasing significant improvements in pathologic response and survival rates. By delving into unique T cell dynamics, this study offers a path towards personalized strategies in oncology.

Don’t miss out on the detailed insights and implications for health economics and patient care! Click to read the full article.

#SyenzaNews #oncology #HealthcareInnovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.